(Q54381818)

10 July 2018

title

[DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer]. (English)

1 reference

10 July 2018

0 references

Haizhu Song

1

1 reference

10 July 2018

Jun Yi

2

1 reference

10 July 2018

Youwei Zhang

3

1 reference

10 July 2018

Rui Wang

4

1 reference

10 July 2018

Longbang Chen

5

1 reference

10 July 2018

language of work or name

Chinese

0 references

publication date

1 March 2011

1 reference

10 July 2018

Chinese Journal of Lung Cancer

published in

1 reference

10 July 2018

volume

14

1 reference

10 July 2018

issue

3

1 reference

10 July 2018

page(s)

233-238

1 reference

10 July 2018

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

[DNA methylation and non-small cell lung cancer].

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Loss of heterozygosity combined with promoter hypermethylation, the main mechanism of human MutL Homolog (hMLH1) gene inactivation in non-small cell lung cancer in a Chinese population.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5999666

Research of loss of heterozygaity on chromosome 3p in non-small cell lung cancer

13 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21426665

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3779/J.ISSN.1009-3419.2011.03.09

1 reference

10 July 2018

PMC publication ID

5999666

1 reference

10 July 2018

PubMed publication ID

21426665

1 reference

10 July 2018